Europe Remote Cardiac Monitoring Market to Grow at a CAGR of 30.2% to reach US$ 5,968.48 million Million from 2021 to 2028

Europe Remote Cardiac Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Devices, Software, and Services) and End User (Hospitals and Clinics, Emergency Settings, Homecare Settings, and Others)

  • Report Code : TIPRE00025818
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 158
Buy Now

The remote cardiac monitoring market in Europe is expected to grow from US$ 943.41 million in 2021 to US$ 5,968.48 million by 2028; it is estimated to grow at a CAGR of 30.2% from 2021 to 2028.



Germany, France, and Italy are major economies in Europe. Increase in preference for remote patient monitoring during COVID-19 pandemic is the major factor driving the growth of the Europe remote cardiac monitoring market. A new era of cardiac management began in 1960 with the creation of the first implantable pacemaker, which has since saved countless lives and transformed the practice of medicine. Furthermore, the implementation of remote patient monitoring (RPM) was a pivotal step in this advancement. In the aftermath of COVID-19, remote monitoring has emerged as a promising solution. A growing number of healthcare providers are using technology-enabled solutions to manage diabetes, improve clinical outcomes, and enhance the patients’ quality of life. Amid the COVID-19 pandemic, compelling people to avoid crowds and going out at public places, healthcare providers are emphasizing providing patient-centered care through virtual medical treatments. Elderly populations suffering chronic diseases, among other people, require frequent check-ups and continuous health monitoring. It is time-consuming for them to drive back and forth to visit physicians, and alternatives such as in-house care are unreasonably expensive for the majority of them. Moreover, they can be at a high risk of COVID-19 infection during hospital visits. These factors have led to the increased adoption of remote patient monitoring. With the rise in the use of remote patient monitoring during the COVID-19 pandemic, many companies have redirected their focus on mergers and acquisitions. Philips has recently agreed to acquire BioTelemetry, a medical technology company that specializes in cardiac diagnostics and remote patient monitoring services. This deal would allow Philips to expand its remote patient monitoring business beyond hospitals and into patients' homes. Philips is already a major player providing remote patient monitoring devices for the hospitals segment. As telemedicine is becoming an integral part of various national healthcare strategies to combat COVID-19, the demand for remote patient monitoring devices that are interoperable with the service provider's telehealth infrastructure is bound to rise, which is further anticipated to drive the market in Europe.

Europe is highly affected by the outbreak of the COVID-19. Countries such as Spain, Italy, the UK, France, Germany, Switzerland, and Russia are highly affected. Most of the deaths were recorded in these nations in the initial phases of the pandemic onset. The EU countries are currently facing the second wave of the pandemic. Therefore, to manage the spread of COVID-19, governments of various countries have implemented lockdown. In the age of COVID-19, digital devices used by patients are increasingly being guided to monitor those who might need hospital admission or who have lately been discharged. In a scheme in northwest London, wearables received the vital signs of people quarantining before or after traveling abroad and healthcare staff who couldn’t isolate themselves at home. A trained team monitored round-the-clock data. If the team detected signs of decline, people could be transferred to the hospital when necessary. Reducing direct contact between people in quarantine and health workers could reduce transmission of SARS-CoV-2 and reduce the use of personal protective equipment.Reliable and timely COVID-19 observation of vital signs is an integral part of the monitoring, prevention, touch recording, and control of infections and clinical management. The outbreak of COVID-19 has led to an increase in the preference for remote monitoring of patients with cardiac diseases. This transformation has been utilized to reduce the chances of viruses due to frequent hospital and clinic visits. Various start-ups have also introduced products that can be used for monitoring cardiac patients. For instance, iRhythm, AliveCor, and medical device giants, such as Medtronic, are actively manufacturing heart-monitoring EKG devices for cardiac patients to use at house and for clinicians to use on COVID-19 patients. It is complex and critical for medical and nursing staff to control COVID-19 patients in person. Patients infected and symptomatic need to be separated in rooms with negative pressure. The new and advanced devices allow staff to monitor such patients more quickly from another room. Multiparametric remote monitoring of cases with heart failure (HF) can alleviate the health risks amid lockdowns. The lockdown restrictions caused a marked drop in healthcare use but did not affect the clinical status of HF patients under multiparametric remote monitoring. Thus, the COVID-19 pandemic increased the demand for healthcare monitoring and awareness, thereby boosting the remote patient monitoring market during the forecast period.
remote patient monitoring market

  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Europe Remote Cardiac Monitoring Market Segmentation         

Europe Remote Cardiac Monitoring Market – By Product Type

  • Devices
    • Vital Signs Monitors
    • Heart Rate Monitors
    • Blood Pressure Monitors
    • Breath Monitors
    • Holter Monitors
    • Others
  • Software
    • Cloud Based Software
    • On-Premise Software
  • Services

Europe Remote Cardiac Monitoring Market – By End User

  • Hospitals and Clinics
  • Emergency Settings
  • Homecare Settings
  • Others

Europe Remote Cardiac Monitoring Market– By Country

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • RoE

Europe Remote Cardiac Monitoring Market-Companies Mentioned

  • Abbott
  • Biotronik, Inc.
  • Boston Scientific Corporation
  • GE Healthcare
  • Honeywell International Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

  1. Abbott
  2. Biotronik, Inc.
  3. Boston Scientific Corporation
  4. GE Healthcare
  5. Honeywell International Inc.
  6. Koninklijke Philips N.V.
  7. Medtronic
  8. Nihon Kohden Corporation
  9. OSI Systems, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Remote Cardiac Monitoring Market